Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/12714
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Greenhalgh, T | - |
dc.contributor.author | Raftery, J | - |
dc.contributor.author | Hanney, S | - |
dc.contributor.author | Glover, M | - |
dc.date.accessioned | 2016-06-03T12:25:19Z | - |
dc.date.available | 2016-05-23 | - |
dc.date.available | 2016-06-03T12:25:19Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | BMC Medicine, 14: 78, (2016) | en_US |
dc.identifier.issn | 1741-7015 | - |
dc.identifier.uri | http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0620-8 | - |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/12714 | - |
dc.description.abstract | Impact occurs when research generates benefits (health, economic, cultural) in addition to building the academic knowledge base. Its mechanisms are complex and reflect the multiple ways in which knowledge is generated and utilised. Much progress has been made in measuring both the outcomes of research and the processes and activities through which these are achieved, though the measurement of impact is not without its critics. We review the strengths and limitations of six established approaches (Payback, Research Impact Framework, Canadian Academy of Health Sciences, monetisation, societal impact assessment, UK Research Excellence Framework) plus recently developed and largely untested ones (including metrics and electronic databases). We conclude that (1) different approaches to impact assessment are appropriate in different circumstances; (2) the most robust and sophisticated approaches are labour-intensive and not always feasible or affordable; (3) whilst most metrics tend to capture direct and proximate impacts, more indirect and diffuse elements of the research-impact link can and should be measured; and (4) research on research impact is a rapidly developing field with new methodologies on the horizon. | en_US |
dc.description.sponsorship | This paper is largely but not entirely based on a systematic review funded by the NIHR HTA Programme, grant number 14/72/01. | en_US |
dc.language.iso | en | en_US |
dc.publisher | BioMed Central | en_US |
dc.subject | Research impact | en_US |
dc.subject | Knowledge translation | en_US |
dc.subject | Implementation science | en_US |
dc.subject | Research utilization | en_US |
dc.subject | Payback Framework | en_US |
dc.subject | Monetisation | en_US |
dc.subject | Research accountability | en_US |
dc.subject | Health gains | en_US |
dc.title | Research impact: A narrative review | en_US |
dc.type | Article | en_US |
dc.identifier.doi | http://dx.doi.org/10.1186/s12916-016-0620-8 | - |
dc.relation.isPartOf | BMC Medicine | - |
pubs.issue | 1 | - |
pubs.publication-status | Published online | - |
pubs.volume | 14 | - |
Appears in Collections: | Health Economics Research Group (HERG) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Fulltext.pdf | 2.54 MB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.